Raising Representation in Clinical Trials: An Interview with Liz Beatty, Inato
The COVID-19 pandemic created a significant shortage of suitable patients for clinical trials worldwide. Within this crisis was another more serious issue around inclusion and representation, driven by COVID’s disparate effect on certain ethnicities, that spoke to a wider issue...
3 years agoRaising Representation in Clinical Trials: An Interview with Liz Beatty, Inato
The COVID-19 pandemic created a significant shortage of suitable patients for clinical trials worldwide. Within this crisis was another more serious issue around inclusion and representation, driven by COVID’s disparate effect on certain ethnicities, that spoke to a wider issue...
3 years ago
Using Translational Research to Bridge the Gap Between Preclinical and Clinical Research
The disparity between animal models and clinical efficacy is compromising the safety and efficacy of therapeutic drugs. Translational research is building the bridge between preclinical studies and therapeutic treatment. Genomic techniques and non-traditional animal models are examples of translational approaches...
4 years agoUsing Translational Research to Bridge the Gap Between Preclinical and Clinical Research
The disparity between animal models and clinical efficacy is compromising the safety and efficacy of therapeutic drugs. Translational research is building the bridge between preclinical studies and therapeutic treatment. Genomic techniques and non-traditional animal models are examples of translational approaches...
4 years ago
Understanding the GP Data Extraction Scheme & Use of Patient Data
The General Practice Data for Planning and Research (GPDPR) is a proposed central NHS digital database collating patient data from GP records in England. Originally 1 July 2021, the date for launch has been pushed back to 1 September after...
4 years agoUnderstanding the GP Data Extraction Scheme & Use of Patient Data
The General Practice Data for Planning and Research (GPDPR) is a proposed central NHS digital database collating patient data from GP records in England. Originally 1 July 2021, the date for launch has been pushed back to 1 September after...
4 years ago
How Has The Covid-19 Pandemic Impacted Oncology and Clinical Operations?
As a part of Proventa’s Clinical Operations and Oncology Meeting May 2021, we organised a number of interesting keynote sessions pondering the latest innovations, challenges and strategies for the future. The morning keynote, hosted by Tanya Russel Kirkpatrick, VP Clinical...
4 years agoHow Has The Covid-19 Pandemic Impacted Oncology and Clinical Operations?
As a part of Proventa’s Clinical Operations and Oncology Meeting May 2021, we organised a number of interesting keynote sessions pondering the latest innovations, challenges and strategies for the future. The morning keynote, hosted by Tanya Russel Kirkpatrick, VP Clinical...
4 years ago
Supporting Diversity in Clinical Trials: An Interview with Ash Rishi, COUCH Health
COVID-19 has changed how many sponsors enrol and retain trial participants. From decentralisation, increased use of wearables and changes in population targeting, the pandemic has seen a shift in both priorities and procedures with regard to enrolment. But is this...
4 years agoSupporting Diversity in Clinical Trials: An Interview with Ash Rishi, COUCH Health
COVID-19 has changed how many sponsors enrol and retain trial participants. From decentralisation, increased use of wearables and changes in population targeting, the pandemic has seen a shift in both priorities and procedures with regard to enrolment. But is this...
4 years ago
Innovations in AI Risk-Based Monitoring in Clinical Research
Risk-based monitoring (RBM) is a useful tool in maximising the quality of clinical trials. Enhanced site communication, greater patient safety and lower costs are a few of the benefits of RBM. The innovations of AI in clinical research have application...
4 years agoInnovations in AI Risk-Based Monitoring in Clinical Research
Risk-based monitoring (RBM) is a useful tool in maximising the quality of clinical trials. Enhanced site communication, greater patient safety and lower costs are a few of the benefits of RBM. The innovations of AI in clinical research have application...
4 years ago
The Impact of Modern Technology on Clinical Operations
The modernisation of clinical research is an important part of expediting the drug approval process, and this in turn is dependent on the success of clinical trials with a sufficient number of appropriate participants. A number of recent innovations promise...
4 years agoThe Impact of Modern Technology on Clinical Operations
The modernisation of clinical research is an important part of expediting the drug approval process, and this in turn is dependent on the success of clinical trials with a sufficient number of appropriate participants. A number of recent innovations promise...
4 years ago
Real World Data and Evidence: Emerging Trends Across Clinical Research
Real-world data (RWD) and real-word evidence (RWE) are increasingly used to support drug development and clinical research across life sciences. RWE studies provide insight into the implementation of therapeutic drugs clinical practice based on RWD of the patient population. RWD...
4 years agoReal World Data and Evidence: Emerging Trends Across Clinical Research
Real-world data (RWD) and real-word evidence (RWE) are increasingly used to support drug development and clinical research across life sciences. RWE studies provide insight into the implementation of therapeutic drugs clinical practice based on RWD of the patient population. RWD...
4 years ago
Precision Medicine in Oncology: A Comparative Evaluation of SMDCs and ADCs
Targeted therapy - a treatment targeting proteins responsible for cancer growth - is one of the latest developments in precision oncology. The variable response of cancer treatments highlights the need to develop therapies that can target the specific profile of...
4 years agoPrecision Medicine in Oncology: A Comparative Evaluation of SMDCs and ADCs
Targeted therapy - a treatment targeting proteins responsible for cancer growth - is one of the latest developments in precision oncology. The variable response of cancer treatments highlights the need to develop therapies that can target the specific profile of...
4 years ago
The Clinical Challenges of Rare Disease Research: An Interview with Dr. Evangeline Wassmer
In a recent interview with Dr. Evangeline Wassmer, Paediatric neurology consultant at Birmingham Children’s Hospital, Proventa discussed the problems with rare disease clinical research. Dr. Wassmer has extensive experience in paedatric rare diseases - paediatric Multiple Sclerosis, neurometabolic and neurodegenerative...
4 years agoThe Clinical Challenges of Rare Disease Research: An Interview with Dr. Evangeline Wassmer
In a recent interview with Dr. Evangeline Wassmer, Paediatric neurology consultant at Birmingham Children’s Hospital, Proventa discussed the problems with rare disease clinical research. Dr. Wassmer has extensive experience in paedatric rare diseases - paediatric Multiple Sclerosis, neurometabolic and neurodegenerative...
4 years ago